Эпилепсия и пароксизмальные состояния (Apr 2022)

Autoimmune epilepsy

  • О. S. Shilkina,
  • E. A. Kantimirova,
  • A. A. Usoltseva,
  • Т. I. Prusova,
  • D. V. Dmitrenko

DOI
https://doi.org/10.17749/2077-8333/epi.par.con.2022.108
Journal volume & issue
Vol. 14, no. 1
pp. 74 – 90

Abstract

Read online

Investigation of autoimmune epilepsy (AIE) has been attracting increasingly more attention due to discovery of neuronal antibodies and improved understanding of the mechanisms related to such immune-mediated syndromes. The review is aimed at autoimmune epilepsy taking into account up-to-date advances in exploring its pathophysiology. Definitions related to this issue are outlined, and pathogenetic mechanisms, features of antineuronal antibodies as well as AIE clinical picture based on type of autoantibodies, are considered. The necessity of regular monitoring patients with AIE is indicated, preferably by an epileptologist together with a neuroimmunologist. With prolonged follow-up, chronic pharmacoresistant epilepsy persists in some patients, despite aggressive immunotherapy and antiepileptic drugs. With a deeper understanding of the mechanisms of antibody-mediated and autoantigen-specific T-cell-mediated AIE syndromes, the use of antiepileptic drugs and immunotherapy can be further optimized.

Keywords